Azacitidine
NDC 70069-857, Azacitidine, injection, powder, lyophilized, for solution, from Somerset Therapeutics LLC.
- Product NDC
- 70069-857
- Status
- Listed
- Labeler
- Somerset Therapeutics LLC
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS, SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA217453
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70069-857 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- AZACITIDINE100 mg/1
Pharmacologic classes
Nucleic Acid Synthesis Inhibitors [MoA]; Nucleoside Metabolic Inhibitor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70069-857-01 | 70069085701 | 1 VIAL, GLASS in 1 CARTON (70069-857-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/3bc4f406-2ec7-7169-e063-6394a90a81d9
Use it
Look up 70069-857 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70069-857 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70069-857. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.